AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
New Class Of Antibody Drug Candidate Discovered.(Brief Article)
2001 SEP 5 - (NewsRx.com & NewsRx.net) --
MorphoSys AG (Mor) and ProChon Biotech, Ltd. announced the discovery of a novel antibody lead resulting from their collaboration initiated in June 2000.
The antibody, representing a new class of drug candidates selected from MorphoSys' HuCAL(R) antibody libraries, was demonstrated by ProChon to specifically block the function of mutated, overactive forms of human growth factor receptors. These mutated forms are associated with inherited skeletal disorders and have been linked to tumor progression and prognosis in several types of cancer, including bladder carcinoma, cervical carcinoma, and multiple myeloma. A patent to protect all rights on the ...
- ProChon Biotech Receives Genzyme Award for Excellence in Cartilage Research at...
- Newspaper article from: Blood Weekly September 17, 2009 700+ words
ProChon Biotech, Ltd., an innovator of tissue regenerative...founder and chief science officer of ProChon Biotech Ltd., who served as lead researcher on the study (see also ProChon Biotech). Under the direction of Dr. Yayon...
- ProChon Biotech Selects Averion International for the BioCart[TM] Cartilage...
- Newspaper article from: Blood Weekly August 20, 2009 700+ words
ProChon Biotech, Ltd., an innovator of tissue...Cartilage Regeneration System (see also ProChon Biotech, Ltd.). Averion brings a 20...years post-implantation. About ProChon Biotech, Ltd. Founded by world leaders...
- ProChon Biotech Wins Genzyme Award for Excellence in Cartilage Research
- Newspaper article from: Wireless News July 2, 2009 700+ words
...Wireless News 07-02-2009 ProChon Biotech Wins Genzyme Award for Excellence...Cartilage Research Type: News ProChon Biotech, a provider of tissue regenerative...and chief science officer of ProChon Biotech, who served as lead researcher...
- ProChon Biotech Selects Lonza to Locally Manufacture Critical Component of...
- Press release article from: Business Wire November 4, 2009 700+ words
...Cartilage Cells WOBURN, Mass. & BASEL, Switzerland -- ProChon Biotech, Ltd., an innovator of tissue regenerative technologies...Further information can be found at www.lonza.com. About ProChon Biotech, Ltd. Founded by world leaders in the field of regenerative...
- ProChon Biotech wins Genzyme prize for cartilage research.(PRIZES)
- Newspaper article from: Biomedical Materials August 1, 2009 700+ words
Specialist in tissue regeneration technologies ProChon Biotech Ltd has won the Genzyme Award for Excellence in Cartilage...For further information, contact: Thomas May, ProChon Biotech Ltd, tel: 508-735-5524; E-mail: tmay@prochon...
- ProChon Biotech Chooses Averion International for the BioCart Cartilage...
- Newspaper article from: Wireless News August 7, 2009 700+ words
Wireless News 08-07-2009 ProChon Biotech Chooses Averion International for the BioCart Cartilage Regeneration System Study Type: News ProChon Biotech, a supplier of tissue regenerative technologies that are being developed to relieve pain...
- Multiple Myeloma Research Foundation (MMRF) Awards $1 Million Each in Funding...
- Press release article from: PR Newswire December 5, 2006 700+ words
...today announced that Semafore Pharmaceuticals, Inc. and ProChon Biotech Ltd. are the recipients of the organization's first LEAD...ongoing development of Semafore Pharmaceuticals' SF1126 and ProChon Biotech's PRO-001 compounds, including their testing in human...
- ProChon Biotech Chooses Averion International for the BioCart Cartilage...
- Magazine article from: Health & Beauty Close-Up August 6, 2009 700+ words
ProChon Biotech, a supplier of tissue regenerative technologies that are being developed to relieve pain and restore the mobility and quality...
Source: HighBeam Research, New Class Of Antibody Drug Candidate Discovered.(Brief Article)